usaherald · 2d
Supreme Court Denies Shkreli’s $64M Disgorgement Rehearing
The U.S. Supreme Court declined on Monday to review former pharmaceutical executive Martin Shkreli's challenge to a $64 million disgorgement order, which was imposed after his alleged scheme to raise the price of a life-saving drug by 4,
Becker's Hospital Review · 1d
Supreme Court turns away Martin Shkreli fine appeal
Mr. Shkreli was convicted of defrauding investors and sentenced in 2018 to seven years in prison; he served about five years. A federal judge also banned Mr. Shkreli from the pharmaceutical industry and ordered him to pay $64.6 million.
devdiscourse · 2d
Supreme Court Denies Shkreli's $64.6 Million Penalty Appeal
The Supreme Court declined to hear Martin Shkreli's appeal against a $64.6 million penalty for raising a drug's price by over 4,000%. The penalty corresponds to profits from raising Daraprim's price and includes a lifetime ban from the drug industry.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results